Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review

Antimicrobial susceptibility testing (AST) is a cornerstone of infection management. Cystic fibrosis (CF) treatment guidelines recommend AST to select antimicrobial treatments for CF airway infection but its utility in this setting has never been objectively demonstrated.

Source: Journal of Cystic Fibrosis - January 29, 2019 Category: Respiratory Medicine Authors: Ranjani Somayaji, Michael D. Parkins, Anand Shah, Stacey L. Martiniano, Michael M. Tunney, Jennifer S. Kahle, Valerie J. Waters, J. Stuart Elborn, Scott C. Bell, Patrick A. Flume, Donald R. VanDevanter, on behalf of the Antimicrobial Resistance in Cystic Tags: Original Article Source Type: research